Your browser doesn't support javascript.
loading
Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa project.
Braulke, Friederike; Para, Servet; Alt-Epping, Bernd; Tewes, Mitra; Bäumer, Markus; Haberland, Birgit; Mayer-Steinacker, Regine; Hopprich, Anne; de Wit, Maike; Grabe, Michaela; Bender-Säbelkampf, Sophia; Weßling, Caroline; Aulmann, Christoph; Gerlach, Christina; Regincos, Pascale; Fischer, Ferdinand; Haarmann, Soraya; Huys, Tatjana; Drygas, Sabine; Rambau, Anett; Kiani, Alexander; Schnabel, Astrid; Buhl, Christoph; Seipke, Stefanie; Hiemer, Sonja; Polata, Silke; Meßmann, Maximilian; Hansmeier, Anna; Anastasiadou, Louiza; Letsch, Anne; Wecht, Daniel; Hellberg-Naegele, Matthias; Krug, Utz; Wedding, Ulrich; van Oorschot, Birgitt.
Affiliation
  • Braulke F; Comprehensive Cancer Center, University Medical Center Göttingen, Göttingen, Germany.
  • Para S; Interdisciplinary Center Palliative Medicine, University Hospital Würzburg, Würzburg, Germany.
  • Alt-Epping B; Department of Palliative Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Tewes M; Department of Palliative Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Bäumer M; Kliniken Maria Hilf GmbH Mönchengladbach, Mönchengladbach, Germany.
  • Haberland B; LMU Klinikum München, München, Germany.
  • Mayer-Steinacker R; Comprehensive Cancer Center Ulm. Medical Center, Ulm University, Ulm, Germany.
  • Hopprich A; Department of Radiooncology and Radiotherapy, University Medical Center Mainz, Mainz, Germany.
  • de Wit M; Cancer Center Berlin-Neukölln - Vivantes Klinikum Neukölln, Berlin, Germany.
  • Grabe M; Cancer Center Rems-Murr-Hospital Winnenden, Winnenden, Germany.
  • Bender-Säbelkampf S; Universitätsklinikum Erlangen, Erlangen, Germany.
  • Weßling C; Clemenshospital Münster, Münster, Germany.
  • Aulmann C; Augsburg University Hospital, Augsburg, Germany.
  • Gerlach C; Department of Palliative Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Regincos P; Clinic of Hematology, Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany.
  • Fischer F; Hospital Ludwigshafen am Rhein gGmbH, Ludwigshafen, Germany.
  • Haarmann S; Kliniken Heilbronn GmbH, Fachklinik Löwenstein, Löwenstein, Germany.
  • Huys T; Universitätsklinikum Gießen, Giessen, Germany.
  • Drygas S; Brüderkrankenhaus St. Josef Paderborn, Paderborn, Germany.
  • Rambau A; Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim, Germany.
  • Kiani A; Klinikum Bayreuth GmbH, and Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Schnabel A; Leipzig University Cancer Center, Leipzig, Germany.
  • Buhl C; Department of Oncology, Hematology, Palliative Medicine, Special Pain Therapy, Hospital Leverkusen, Leverkusen, Germany.
  • Seipke S; Comprehensive Cancer Center, Hannover Medical School, Hannover, Germany.
  • Hiemer S; Klinikum St. Georg Leipzig, Leipzig, Germany.
  • Polata S; Evangelisches Waldkrankenhaus Berlin-Spandau, Berlin, Germany.
  • Meßmann M; Department of Palliative Medicine, Hospital St. Elisabeth Straubing GmbH, Straubing, Germany.
  • Hansmeier A; Mathias-Spital Rheine-Ibbenbüren, Rheine, Germany.
  • Anastasiadou L; Agaplesion Markus Krankenhaus Frankfurt, Frankfurt, Germany.
  • Letsch A; Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Wecht D; Specialist Care in Oncology and Palliative Care, University Hospital Gießen and Marburg, Marburg, Germany.
  • Hellberg-Naegele M; Advanced Practice Nurse, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Krug U; Department of Oncology, Hematology, Palliative Medicine, Special Pain Therapy, Hospital Leverkusen, Leverkusen, Germany.
  • Wedding U; Department of Palliative Care, University Hospital Jena, Am Klinikum 1, 07747, Jena, Germany. ulrich.wedding@med.uni-jena.de.
  • van Oorschot B; Interdisciplinary Center Palliative Medicine, University Hospital Würzburg, Würzburg, Germany.
J Cancer Res Clin Oncol ; 149(11): 8829-8842, 2023 Sep.
Article de En | MEDLINE | ID: mdl-37145199
ABSTRACT

PURPOSE:

Guidelines recommend a structured symptom screening (SC) for especially advanced cancer patients (CPs). The aim of this multicenter German prospective quality assurance project KeSBa (Kennzahl Symptom- und Belastungserfassung) was to gain knowledge on SC procedures in Oncology Centers (OCs) for advanced cancer patients and a first impression on the consequences of SC.

METHODS:

The KeSBa project consisted of three phases pilot, 3 months screening and feedback phase. Participating OCs decided to use either the Minimal Documentation System (MIDOS) or the Integrated Palliative care Outcome Scale (IPOS) and defined the cutoff values for positive screening results.

RESULTS:

Out of 172 certified German OCs, 40 (23%) participated in the KeSBa pilot phase, 29 (16.8%) in the 3 months screening phase using MIDOS (n = 18, 58.6%) or IPOS (n = 11, 41.3%) and in the feedback round. 25/29 performed paper-based screening (86.2%). 2.963 CPs were screened. Results were documented for 1255 (42.2%, SC +) positive and 874 (29.5%, SC-) negative screenings depending on the center´s schedules 452 SC + CPs (28.4%) and 42 SC- CPs (2.6%) had contact to specialized palliative care or other supportive specialist teams afterwards, 458 SC + CPs (28.8%) and 605 SC- CPs (38.1%) remained in standard oncology care. In the feedback round missing resources (personal and IT) and improved communication were mentioned most often.

CONCLUSION:

Routine SC is feasible in advanced CPs treated in OCs but associated with considerable workload. In 42.2% of CPs SC was classified as positive, indicating the need of further diagnostics or professional judgment. SC requires staff and IT resources.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dépistage précoce du cancer / Tumeurs Type d'étude: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Risk_factors_studies / Screening_studies Limites: Humans Langue: En Journal: J Cancer Res Clin Oncol Année: 2023 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dépistage précoce du cancer / Tumeurs Type d'étude: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Risk_factors_studies / Screening_studies Limites: Humans Langue: En Journal: J Cancer Res Clin Oncol Année: 2023 Type de document: Article Pays d'affiliation: Allemagne